Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	293.24	111.97	28.47
Graham Fair Price	-31.74	33528.13	49117.90
PEG	161.64	-0.12	0.04
Price/Book	14.56	0.39	0.34
Price/Cash Flow	-29.90	5.67	-8.09
Prices/Earnings	157.77	6.32	2.45
Price/Sales	13.48	0.61	0.54
Price/FCF	-29.90	5.67	-8.09
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-31.47	0.09	0.13
Operating Margin	-34.22	0.06	0.08
ROA	-54.35	< 0.005	< 0.005
ROE	0.03	0.02	-55.56
ROIC	0.01	< 0.005	-55.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	5.00	-99.53
Dividends QOQ	-0.21	-1.00	-372.64
EBIT QOQ	-0.04	-0.32	-641.33
EPS QOQ	0.55	-0.54	-1.48
FCF QOQ	-2.23	2.67	19.72
Revenue QOQ	-0.08	0.03	-57.40
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	40.64	36.63	-9.87
Days Sales Outstanding (DSO)	48.70	41.56	-14.67
Inventory Turnover	2.21	2.46	10.95
Debt/Capitalization	0.79	0.78	-1.02
Quick Ratio	0.32	0.26	-17.11
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	55836.52	57172.07	2.39
Cash	11390.24	9390.11	-17.56
Capex	-5691.53	-5812.08	-2.12
Free Cash Flow	-2328.59	3896.44	67.33
Revenue	35100.05	36283.56	3.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.48	0.42	-13.82
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	26.10	101.05	287.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating